160 related articles for article (PubMed ID: 20002768)
1. Oncocytic versus mitochondrion-rich follicular thyroid tumours: should we make a difference?
Tsybrovskyy O; Rössmann-Tsybrovskyy M
Histopathology; 2009 Dec; 55(6):665-82. PubMed ID: 20002768
[TBL] [Abstract][Full Text] [Related]
2. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
[TBL] [Abstract][Full Text] [Related]
3. Oncocytic carcinoma of the breast: frequency, morphology and follow-up.
Ragazzi M; de Biase D; Betts CM; Farnedi A; Ramadan SS; Tallini G; Reis-Filho JS; Eusebi V
Hum Pathol; 2011 Feb; 42(2):166-75. PubMed ID: 21111455
[TBL] [Abstract][Full Text] [Related]
4. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
5. The C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours.
Sheu SY; Handke S; Bröcker-Preuss M; Görges R; Frey UH; Ensinger C; Ofner D; Farid NR; Siffert W; Schmid KW
J Pathol; 2007 Jan; 211(1):60-6. PubMed ID: 17136758
[TBL] [Abstract][Full Text] [Related]
6. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
7. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
8. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
[TBL] [Abstract][Full Text] [Related]
9. Aspiration cytology of the oncocytic variant of papillary adenocarcinoma of the thyroid gland.
Moreira AL; Waisman J; Cangiarella JF
Acta Cytol; 2004; 48(2):137-41. PubMed ID: 15085743
[TBL] [Abstract][Full Text] [Related]
10. [Askenazi (Hurtle) cell tumors of the thyroid].
Raĭkhlin NT; Smirnova EA; Pavlovskaia AI; Rotin DL; Gurevich LE; Savelov NA
Arkh Patol; 2005; 67(6):13-6. PubMed ID: 16405013
[TBL] [Abstract][Full Text] [Related]
11. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
12. Dense-core matrical mitochondrial bodies in oncocytic adenoma of the thyroid.
David R; Kim KM
Arch Pathol Lab Med; 1983 Apr; 107(4):178-82. PubMed ID: 6299227
[TBL] [Abstract][Full Text] [Related]
13. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid.
Cho Mar K; Eimoto T; Nagaya S; Tateyama H
Histopathology; 2006 Jun; 48(7):801-7. PubMed ID: 16722928
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of thyrotropin receptor gene suggests a high-risk subgroup for oncocytic adenoma.
Mirebeau-Prunier D; Guyétant S; Rodien P; Franc B; Baris O; Rohmer V; Reynier P; Tourmen Y; Malthièry Y; Savagner F
Eur J Endocrinol; 2004 Mar; 150(3):269-76. PubMed ID: 15012610
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid.
Volante M; Bozzalla-Cassione F; DePompa R; Saggiorato E; Bartolazzi A; Orlandi F; Papotti M
Virchows Arch; 2004 Aug; 445(2):183-8. PubMed ID: 15252732
[TBL] [Abstract][Full Text] [Related]
18. Analysis of P161NK4A protein expression in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
Pol J Pathol; 2004; 55(4):143-8. PubMed ID: 15757201
[TBL] [Abstract][Full Text] [Related]
19. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
20. Oncocytic Change in Thyroid Pathology.
Asa SL; Mete O
Front Endocrinol (Lausanne); 2021; 12():678119. PubMed ID: 34012422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
